By NewsDesk @bactiman63 Florida Poison Control tweeted last week that they are seeing a spike in cases related to ivermectin, a deworming medication. They report treating 27 patients in August, primarily...

By NewsDesk @bactiman63 Ivermectin is a U.S. Food and Drug Administration (FDA)-approved prescription medication used to treat certain infections caused by internal and external parasites. During the...

By NewsDesk @bactiman63 Boston-based biopharmaceutical company, Paratek Pharmaceuticals announced the novel, once-daily oral and intravenous antibiotic NUZYRA® (omadacycline) has recently been added...

Only 21 percent of patients with severe pneumonia caused by SARS-CoV-2 (the virus that causes COVID-19) have a documented bacterial superinfection at the time of intubation, resulting in potential overuse...

By NewsDesk  @infectiousdiseasenews The US Food and Drug Administration (FDA) put out a tweet Saturday that has garnered a lot of attention (with 36.6K retweets as of this writing) which states: You...

By NewsDesk  @infectiousdiseasenews The Mississippi state health authorities issued a health alert Friday due to increased Poison Control calls due to ivermectin ingestion and potential toxicity. The...

A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, reveals a study in the laboratory by...

AbbVie announced Friday that the U.S. Food and Drug Administration (FDA) approved DALVANCE® (dalbavancin) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric...

By NewsDesk  @infectiousdiseasenews The US Food and Drug Administration (FDA) has approved fexinidazole as the first all-oral treatment for both stages of sleeping sickness (human African trypanosomiasis). Fexinidazole was...

By NewsDesk  @infectiousdiseasenews Morristown, NJ pharmaceutical company, Melinta Therapeutics announced this week that their lipoglycopeptide antibiotic, KIMYRSA™ (oritavancin), is now commercially...